TMCnet News
TraceLink Unveils FutureLink: New Annual Conference Addressing Supply Chain Compliance and Exploring the Future of Digital Drug Supply with Information Sharing NetworksInnovative Symposium for Pharmaceutical and Healthcare Industries to Take Place in both Europe and U.S. in 2018 NORTH READING, Massachusetts, Dec. 6, 2017 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today unveiled FutureLink—a new and innovative annual gathering of commercial and operational executives from the pharmaceutical and healthcare industries who are dedicated to achieving regulatory compliance and shaping the future of digital drug supply with information sharing networks. As the only conference of its kind, FutureLink Munich will occur in June 2018, with FutureLink Chicago taking place in November 2018. Both events will provide a forum for a range of business leaders to foster innovative thinking, discuss actionable insights, and develop strategies that address rapidly approaching compliance deadlines—and the analog-to-digital information-sharing transformation taking place in the pharmaceutical and healthcare industries. Taking place on June 5 – 7, 2018, roughly eight months prior to the February 2019 EU FMD compliance deadline, FutureLink Munich will offer tailored conference experiences for:
"The pharmaceutical and healthcare industries are in the midst of a massive transition. New regulations require complex digital connectivity and data exchange between trading partners, and primitive business procsses and architectures are barriers to efficiently manage product recalls, returns, inventory, and more," said Shabbir Dahod, president and CEO of TraceLink. "By connecting more than 700 pharmaceutical manufacturers, distributors, hospitals and pharmacies to over 260,000 trading partners on our network, we've digitized the world's prescription drug supply chain, providing companies with the best platform for achieving compliance and transformational business value. At FutureLink, industry decision makers will come together to discuss compliance best practices and strategize about how to take advantage of real-time, collaborative information sharing that enables them to operate more cost effectively and deliver better patient outcomes." FutureLink Munich: Unique Learning Paths for Executive Leaders with Compliance and Commercial Business Interests Designed for both commercial and operational executives from the pharmaceutical and healthcare industries, FutureLink will deliver content that is customized for executives with interests in regulatory compliance and commercial initiatives. Compliance-specific sessions will center on:
Commercial and value-oriented tracks will explore:
Both groups will have the opportunity to experience visionary keynotes, hands-on knowledge sessions, special interest group discussions, and networking with TraceLink partners, with but with content that caters to their specific interests. Registration for FutureLink Munich is now open. For more information and to reserve a seat, please visit FutureLink Munich. About TraceLink TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
|